October 7, 2022
Sponsored by Chemical Resources
Most men over the age of 40 start facing urinary problems. All these problems are linked to the non-malignant enlargement of the prostate. Benign Prostate Hyperplasia (BPH) is considered a normal condition of male aging.
PROSMAN is an innovative product derived from prunus domestica that has anti-inflammatory and antioxidant effects by inhibiting the production of pro-inflammatory prostaglandins in the prostate. It has been derived from prunus domestica stems and comprises active constituents beta-sitosterol & docosyl ferulate.
After thorough research, we developed an innovative process for the extraction of Prosman. A clinical study was conducted on 140 men confirming its safety and efficacy. The patients were benefited with a significant reduction in IPSS score, prostate volume, and serum PSA levels. Prosman is a well-researched and published ingredient supported with clinical studies and patents granted by US, Europe, China, Japan, India and Korea.
For more information, visit www.chereso.net
Download now to learn more!
You May Also Like
Advancing gender equity in the nutraceutical industrySep 25, 2023
CRN petition to FTC: RCTs aren’t required to substantiate ‘health-benefit’ claimsSep 22, 2023
Collagen peptide ingredient solutions for seniors’ changing needs – infographicSep 19, 2023
Radicle Insights—Covid Eris and dietary supplements: separating fact from fictionSep 21, 2023